M.G. Pharma SRL
M.G. Pharma reported total assets of 729,401 € at the end of the 2025 financial year (annual accounts filed with the NBB on 22 Jul 2026).
The score of M.G. Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
M.G. Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 22 Jul 2026
- Year ended 31 Dec 2024filed on 25 Aug 2025
M.G. Pharma's financial analysis
- Solvency2.6%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of M.G. Pharma
M.G. Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1002.433.830
- VAT number
- BE1002433830
- Peppol
- Registered · 0208:1002433830 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 20 Nov 2023
- Registered office
- 4520 Wanze
- Latest accounts
- 2025 · filed on 22 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
M.G. Pharma (SRL) has been based in Wanze since 2023, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 16,390 € and equity of 18,936 €; its revenue is not published. Its solvency stands at 2.6%, below the median of its sector (41.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to M.G. Pharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie de Saint-Vaast Retail sale of pharmaceutical products La Louvière · balance sheet 999,556 €
- Extrapharm Waremme Retail sale of pharmaceutical products Waremme · balance sheet 936,866 €
- Apotheek Wijnberg Retail sale of pharmaceutical products Wevelgem · balance sheet 786,727 €
- R&B Farma Retail sale of pharmaceutical products Antwerp · balance sheet 521,346 €
- Astella Retail sale of pharmaceutical products Bilzen-Hoeselt · balance sheet 603,476 €
- ViOph.arma Retail sale of pharmaceutical products Frameries · balance sheet 689,435 €
- Geassocieerde Apotheek Piot Retail sale of pharmaceutical products Antwerp · balance sheet 784,378 €
- Paques Pharma Retail sale of pharmaceutical products Profondeville · balance sheet 797,673 €
Frequently asked questions about M.G. Pharma
What is the revenue of M.G. Pharma?
M.G. Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of M.G. Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE1002433830 for M.G. Pharma, if the company is VAT-registered. Its company number (CBE) is 1002.433.830.
Where is the registered office of M.G. Pharma?
According to the CBE register, the registered office of M.G. Pharma is in 4520 Wanze.
What is the equity of M.G. Pharma?
At the close of the 2025 financial year, the equity of M.G. Pharma amounts to 18,936 €, a solvency of 2.6% of total assets.
Who manages M.G. Pharma?
The register lists 1 active mandates at M.G. Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of M.G. Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →